Marsh McLennan Shares Face Multi-Pronged Challenges
Published on 11/13/2025 at 08:46 | Redaktion boerse-global.de
Marsh McLennan finds itself navigating turbulent waters as legal disputes intensify and market sentiment sours. The insurance conglomerate is simultaneously battling a rival firm in court, confronting former employees over alleged corporate espionage, and facing downward revisions from financial analysts.
Financial institutions have recently taken a more cautious stance toward Marsh McLennan’s prospects. Bank of America made a significant adjustment to its rating, downgrading the stock from “Neutral” to “Underperform” while slashing its price target substantially from $243 to $181. Analysts cited moderated growth expectations and declining property rates as primary concerns. This move follows similar downward revisions from Barclays, Evercore ISI, and other firms since late October.
Despite these Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
